Moderna Stock Falls On Potential FDA Delay For Covid Vaccine In Teens

·2 min read
Moderna Stock Falls On Potential FDA Delay For Covid Vaccine In Teens

Moderna stock dipped Friday on a report the FDA is delaying its review of the company's Covid vaccine in teens.